Major histocompatibility complex–peptide–T cell receptor complex at the immunological synapse (MHC-peptide–TCR complex)

The major histocompatibility complex–peptide–T cell receptor complex at the immunological synapse is an assembly of proteins formed at the interface between a T lymphocyte and an antigen-presenting cell (APC). In this complex, the T cell receptor (TCR) on the T cell recognizes an antigenic peptide presented by the major histocompatibility complex (MHC) molecule on the APC. The specific recognition and binding trigger a cascade of signal transduction events that activate the T cell, initiating adaptive immune responses. The immunological synapse encompasses additional molecules, including coreceptors (CD4 or CD8), adhesion proteins (such as LFA-1/ICAM-1), and the intracellular signaling apparatus (CD3 complex), creating a highly organized interface that coordinates antigen recognition, signaling, and effector function. Dysregulation or manipulation of this complex underlies multiple diseases, including cancer, autoimmunity, infection, and transplant rejection, and represents a central target for immunotherapeutic strategies.

Other names

pMHC–TCR complexTCR–pMHC complexPeptide–MHC–TCR complexT cell immunological synapseTCR-antigen complex

Blocking inhibitory signals (immune checkpoint blockade) Redirecting T cell specificity (engineered TCRs) Enhancing antigen presentation (peptide/protein vaccines) Inhibiting TCR signaling cascades (kinase inhibitors, immunosuppressants)